Study contact | Number of completed C30 and site-specific questionnaires/eligible patients | Diagnoses of patients who filled out the questionnaires/eligible patients | Overall response rates |
---|---|---|---|
Baseline | 21/22 | 14/14 PC 4/5 CRC 3/3 BC | 95% |
6 week follow-up | 20/22 | 13/14 PC 5/5 CRC 2/3 BC | 91% |
12 week follow-up | 17/22 | 11/14 PC 4/5 CRC 2/3 BC | 77% |